Top Markets
Coin of the day
Angion Biomedica Corp. Angion Biomedica Corp.

Angion Biomedica Corp.

ANGN
Hisse Senetlerindeki Sıralama #27862
Angion Biomedica Corp. operates as a biopharmaceutical enterprise,... Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Hisse Fiyatı
$1.00
Son senkronizasyon: 2023-06-01
Piyasa Değeri
$30.11M
Değişim (1 gün)
2.04%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Angion Biomedica Corp. (ANGN)

Kategori

Angion Biomedica Corp. (ANGN) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.00 - 2023-06-01

Gün sonu en düşük fiyat: $20.49 - 2021-02-01
Angion Biomedica Corp. için hisse fiyatı geçmişi: 2021 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2023 18.73%
2022 -70.78%
2021 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$122.66 -13.63%
AU
$753.28 5.84%
CH